UNSPSC 51173220: Carboxymethylcellulose/docusate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173220 Carboxymethylcellulose/docusate is a Commodity code that covers pharmaceutical active ingredients and finished dosage forms containing these agents. Recent state and local procurement under this code reflects demand for drug-testing specimen collection services, generic pharmaceutical supply agreements, and direct-to-manufacturer pharmacy programs. The issuing bodies span state health agencies, county criminal justice departments, and multistate cooperative purchasing alliances. Work solicited includes specimen collection and immunoassay testing operations, generic drug sourcing and pricing agreements with wholesaler distribution networks, and vendor capability assessments for direct pharmaceutical procurement models outside traditional pharmacy benefit manager arrangements.

Activity concentrates in Texas and Minnesota. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, requesting offender specimen collection and drug testing services with proposals due July 23, 2026 at 2:00 p.m., covering staffing of two collection sites, immunoassay screening with LC/MS/MS or GC/MS confirmation, and alternative testing methodologies including oral fluid and hair testing on approximately 25,031 tests annually under a two-year contract valued at $600,000 with three optional one-year renewals. The Texas Health and Human Services Commission issued RFI HHS0017013 on March 27, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs for state pharmacy benefit operations. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted RFP S1070000015802 on January 20, 2026 with proposals due March 26, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities, including Oregon, requiring vendors to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC.